IHC Antibodies

IHC antibodies are optimized for immunohistochemistry, enabling in-situ localization and semi‑quantitative analysis of target proteins in tissue sections.They are widely used in pathological diagnosis (e.g., breast cancer subtyping of ER/PR/HER2), spatial distribution research of proteins, prognostic evaluation (Ki‑67, PD‑L1, etc.), and drug target validation.Selection should consider sample type, antigen expression level, subcellular localization, compatibility with automated staining platforms, and multiplex staining requirements.